Codes ATC:
L01AA09
Indication
Follicular lymphoma
Code ICD11:
2B50.Z
INN
Bendamustine
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Parenteral > General injections > unspecified:
45 mg per 0.5 mL ;
180 mg per 2 mL
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Main patents have expired but secondary patents might remain active in some jurisdictions. For more
information on specific patents and license status for developing countries visit www.MedsPal.org
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, bendamustine was added to the complementary list of the EML for use in treatment protocols for follicular lymphoma.
The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for follicular lymphoma is attached.